Yen‐Chun Wang
Papers
1
Total Citations
3
H-Index
1
About
Dr. Yen‑Chun Wang is a urologic oncologist whose research centers on optimizing treatment outcomes for prostate cancer, with a particular focus on the prognostic significance of positive surgical margins and the role of adjuvant therapy. In a landmark 2025 study, Dr. Wang led a comprehensive analysis of 111 patients who underwent radical prostatectomy, systematically evaluating how positive surgical margins correlate with biochemical recurrence. This work demonstrated that adjuvant therapy can significantly reduce the risk of recurrence in this high‑risk population, providing crucial evidence for clinical decision‑making. The study has already garnered 3 citations, reflecting its immediate relevance to practicing urologists and oncologists. Dr. Wang’s contributions are notable for bridging the gap between surgical pathology and postoperative management, offering a data‑driven framework to personalize treatment after radical prostatectomy. By clarifying which patients benefit most from early intervention, Dr. Wang’s research directly impacts long‑term cancer control and quality of life, establishing him as a thoughtful voice in the evolving landscape of prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1